TW
XBI icon

TrinityPoint Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TrinityPoint Wealth’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.77M Buy
19,701
+236
+1% +$22.9K 0.25% 96
2024
Q3 		$1.92M Buy
19,465
+1
+0% +$98 0.28% 91
2024
Q2 		$1.8M Buy
19,464
+4
+0% +$359 0.28% 90
2024
Q1 		$1.85M Buy
19,460
+360
+2% +$33.4K 0.31% 85
2023
Q4 		$1.71M Sell
19,100
-26,170
-58% -$1.94M 0.31% 80
2023
Q3 		$3.31M Sell
45,270
-650
-1% -$51.9K 0.66% 35
2023
Q2 		$3.82M Sell
45,920
-7,040
-13% -$589K 0.75% 29
2023
Q1 		$4.04M Buy
52,960
+250
+0.5% +$20.7K 0.86% 25
2022
Q4 		$4.37M Sell
52,710
-300
-0.6% -$24.3K 1% 23
2022
Q3 		$4.21M Buy
53,010
+1,472
+3% +$124K 0.96% 23
2022
Q2 		$3.83M Buy
51,538
+44,084
+591% +$3.31M 0.85% 29
2022
Q1 		$670K Sell
7,454
-22,045
-75% -$2.04M 0.12% 144
2021
Q4 		$3.3M Buy
29,499
+24,196
+456% +$2.92M 0.59% 49
2021
Q3 		$667K Sell
5,303
-100
-2% -$12.9K 0.13% 140
2021
Q2 		$732K Sell
5,403
-400
-7% -$52.6K 0.15% 134
2021
Q1 		$787K Sell
5,803
-42,753
-88% -$6.4M 0.18% 118
2020
Q4 		$7.5M Sell
48,556
-10,850
-18% -$1.39M 1.8% 9
2020
Q3 		$6.62M Buy
59,406
+40,202
+209% +$4.51M 1.84% 9
2020
Q2 		$2.15M Buy
19,204
+7,065
+58% +$696K 0.68% 39
2020
Q1 		$940K Hold
12,139
– – 0.37% 74
2019
Q4 		$1.16M Sell
12,139
-500
-4% -$43.3K 0.39% 67
2019
Q3 		$1.05M Sell
12,639
-905
-7% -$75.2K 0.37% 74
2019
Q2 		$1.17M Sell
13,544
-5,900
-30% -$503K 0.56% 48
2019
Q1 		$1.76M Buy
19,444
+2,436
+14% +$207K 0.87% 29
2018
Q4 		$1.22M Buy
+17,008
New +$1.37M 0.75% 35

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

TrinityPoint Wealth's XBI Position: Q4 2024 in Review

TrinityPoint Wealth increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.2% in Q4 2024, buying an estimated $22.9K and bringing the position to 19,701 shares worth $1.77M. The position accounts for 0.25% of the portfolio, ranked #96.

TrinityPoint Wealth first reported a position in XBI in Q4 2018 and has held it in 25 quarters since. The position peaked at $7.5M in Q4 2020. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • TrinityPoint Wealth held 19,701 shares of State Street SPDR S&P Biotech ETF worth $1.77M as of Q4 2024.
  • TrinityPoint Wealth bought 236 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $22.9K.
  • State Street SPDR S&P Biotech ETF made up 0.25% of TrinityPoint Wealth's portfolio in Q4 2024, its #96 holding.
  • TrinityPoint Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 25 quarters since.
  • TrinityPoint Wealth's State Street SPDR S&P Biotech ETF position peaked at $7.5M in Q4 2020.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.